About Kranus Health

Kranus Health aims to help men lead healthier and longer lives through access to the latest medical care. Founders Thilo Kleinschmidt and Jens Nörtershäuser have known each other for many years through their time together at McKinsey & Company, and both have been passionate about the possibilities of digital transformation for years. Both also had a keen interest in the health sector. Jens is originally a bio-chemical engineer and has years of professional experience in the pharmaceutical sector. Thilo comes from a medical family, his father is a urologist. So the idea to found Kranus at the beginning of 2020 was obvious and also took place against the backdrop of regulatory changes, especially the Digital Health Care Act (DVG). Since then, it has been possible in Germany to significantly improve healthcare through digital therapies. Professor Kurt Miller, former head physician of urology at Charité Berlin, and CTO Nikolay Dimolarov (Celonis, among others) complement the founding team to jointly implement Kranus' vision. To this end, Kranus Health develops digital therapies based on current scientific findings supported by telemedical care from specialists. The spectrum of services ranges from therapies for taboo diseases such as erectile dysfunction to early detection and prevention (e.g., cardiovascular diseases).

Press releases

2. October 2023

Kranus Health now raised a total of USD 15 million Series A funding to realize its vision of integrated care in urology

Berlin / Munich / Paris, 2th of October 2023 – Kranus Health, specializing in integrated care within urology, announces that the company is now funded with a Series A round totalling USD 15 million. The round is co-led by new investor SwissHealth Ventures and existing investor, Karista. All other existing investors including HTGF, Wenvest and A Round Capital, have also made significant follow-on investments. The new funds make Kranus Health one of the best-funded digital health startups in
21. June 2022

Kranus Health closes Series A financing and has now raised a total of 8 million USD for digital men’s health

Kranus Health, the company behind the world’s first prescription digital therapeutic to treat erectile dysfunction, announces the successful closing of its Series A at over 6.5 million US dollars. The latest financing round increases the total funding of Kranus Health to 8 million USD, which the company collected in just 22 months after its inception. The current round was led by French health care investor Karista, Austria-based Family Office Peak Pride also joined the round. All exis
4. February 2021

Kranus Health receives seven-figure Seed investment to revolutionize Men’s Health

Today, the digital men’s health platform Kranus Health announced a seven-figure Seed investment. HTGF, A Round Capital, Venture Basecamp and Dr. Ralph Müller are joining Kranus Health as new investors in this round. In addition to new investors, existing business angels, including Konstantin Mehl (founder Foodora + Kaia Health), have done follow-on investments in the Seed round. With the fresh capital, Kranus Health will further expand its men’s health platform and, as a next st

Info & Contact

Jens Nörtershäuser


Westenriederstr. 10,
80331 München

In portfolio

29. Jan 2021

Louis Heinz

Senior Investment Manager